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Linkage analyses of complex, multifactorial traits and diseases, such as essential hypertension, have been difficult to
interpret and reconcile. Many published studies provide evidence suggesting that different genes and genomic regions
influence hypertension, but knowing which of these studies reflect true positive results is challenging. The reasons for this
include the diversity of analytical methods used across these studies, the different samples and sample sizes in each study,
and the complicated biological underpinnings of hypertension. We have undertaken a comprehensive linkage analysis of
371 autosomal microsatellite markers genotyped on 4,334 sibling pairs affected with hypertension from five ethnic groups
sampled from 13 different field centers associated with the Family Blood Pressure Program (FBPP). We used a single
analytical technique known to be robust to interpretive problems associated with a lack of completely informative markers
to assess evidence for linkage to hypertension both within and across the ethnic groups and field centers. We find evidence
for linkage to a number of genomic regions, with the most compelling evidence from analyses that combine data across field
center and ethnic groups (e.g., chromosomes 2 and 9). We also pursued linkage analyses that accommodate locus
heterogeneity, which is known to plague the identification of disease susceptibility loci in linkage studies of complex
diseases. We find evidence for linkage heterogeneity on chromosomes 2 and 17. Ultimately our results suggest that evidence
for linkage heterogeneity can only be detected with large sample sizes, such as the FBPP, which is consistent with theoretical
sample size calculations. Genet. Epidemiol. 31:195–210, 2007. r 2007 Wiley-Liss, Inc.
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INTRODUCTION
Hypertension, defined as systolic and/or dia-
stolic blood pressure (BP) readings greater than
140 and/or 90 mmHg, respectively, affects ap-
proximately 50 million Americans. Diseases asso-
ciated with, and mediated by, hypertension, such
as coronary artery disease, stroke, heart failure,
and renal disease, constitute a major public health
concern and burden [Burt et al., 1995; Whelton,
1994]. Because of its importance, a number of
studies have been undertaken to identify the
genetic and environmental risk factors underlying
susceptibility to hypertension [Schork et al., 1999].
r 2007 Wiley-Liss, Inc.
Although these studies have shed a great deal of
light on the pathogenic mechanisms contributing
to hypertension, genetic studies, in particular
whole genome linkage studies, have been hard
to reconcile, especially in the context of the
analysis of the common non-Mendelian form of
hypertension known as ‘‘essential’’ hypertension.
Essential hypertension is a complex, multifac-
torial disorder with many genetic and environ-
mental determinants [Schork et al., 1999; Ward,
1990]. Although many published studies have
provided evidence that specific inherited genetic
variations influence BP regulation and hyperten-
sion, many, if not most, of these studies have not
been replicated, as is true with most association
studies for complex traits [Hirschhorn et al., 2002].
What are more problematic than association
studies for complex traits and diseases are
family-based linkage studies, where a lack of
replication and statistical power issues are even
more pronounced [see e.g., Altmuller et al., 2001;
Risch and Botstein, 1996]. It has been argued that
one of the main reasons that association and
linkage studies are not replicated is that the
genetic determinants of complex traits, such as
hypertension, are heterogeneous, in the sense that
different sets of individuals may have inherited
different sets of susceptibility factors [Ioannidis
et al., 2004]. In addition, it has been proposed that
some of the factors predisposing to disease
identified in one study are unique to the popula-
tion or sample used in that study and, hence, are
not likely to be found in another population or
sample [Ioannidis et al., 2004]. What is important
in this regard is the notion that the individuals
used in any one study may themselves exhibit
such heterogeneity, and this heterogeneity would
need to be accommodated or accounted for if
evidence for genetic influences on a trait of
interest is to be found.
The irreconcilability of genetic linkage studies of
essential hypertension is likely a function of the
different ways in which one can define hyperten-
sion, as well as the complex, multifactorial nature
of susceptibility to hypertension. However, it also
clearly reflects the non-uniform methodologies
used in the linkage analyses, as has been argued in
many reviews of general linkage analysis findings
[Risch and Botstein, 1996; Altmuller et al., 2001].
For example, many linkage studies are known to
be plagued by the use of relatively small sample
sizes, despite the numerous recommendations
and guidelines for the use of large sample sizes
published in the literature [Kruglyak and Lander,
1995; Williams and Blangero, 1999, 2004; Schork,
1993]. In addition, many different statistical
methods for linkage analysis have been devised,
each with its own advantages and disadvantages,
which produce results that are hard to reconcile
unless one accounts for the methodological
differences [Goldgar, 2001]. Finally, many studies
have examined hypertension within different
racial, ethnic, and/or geographically defined
populations, making it difficult to determine
whether the differences in the results reflect
population specificity and heterogeneity in the
genetic determinants of hypertension or whether
they reflect differences in methodological issues
that have resulted in false positive results within
at least some of these populations.
In an effort to overcome problems plaguing the
identification of genes contributing to hyperten-
sion susceptibility associated with methodologi-
cal, population heterogeneity, and sample size
issues, the National Heart, Lung, and Blood
Institute (NHLBI) initiated the Family Blood
Pressure Program (FBPP). The FBPP was estab-
lished in 1995 to study the genetic determinants of
hypertension and is comprised of four separate
research networks, each with its own team of
researchers and sample collection units: (1) Gen-
Net (Genetic Network); (2) GENOA (Genetic
Epidemiology Network of Atherosclerosis); (3)
HyperGEN (Hypertension Genetic Epidemiology
Network); and (4) SAPPHIRe (Stanford Asian
Pacific Program in Hypertension and Insulin
Resistance) [http://www.biostat.wustl.edu/fbpp/
FBPP.shtml; The FBPP Investigators, 2002]. Taken
together, the four FBPP networks comprise 13
field centers that have enrolled individuals from
five ethnic groups: African American, Mexican
American, Japanese, Chinese, and Caucasian.
Although each network has a slightly different
research focus, resulting from the investigators’
unique areas of expertise, a common set of core
phenotypes, genotyping protocols, and standar-
dized measurement methods are employed by all.
The FBPP to date has produced one of the largest
collection of families with members affected by a
single disease that have been genotyped on the
same set of genetic markers for linkage studies.
The large number of subjects in the FBPP
provides excellent statistical power to detect small
genetic effects in linkage analysis contexts and
permits in-depth analyses using various subsets
of the study participants. However, despite the
power of the FBPP sample, the latest results from
genome-wide linkage scans for either hyperten-
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sion or BP have not provided highly significant
evidence for linkage to any single genomic region
[Rao et al., 2003; Thiel et al., 2003; Kardia et al.,
2003; Ranade et al., 2003; Province et al., 2003;
Wu et al., 2006; see Table I for a summary]. This
may reflect the subtle methodological differences
implemented in these studies. We have therefore
chosen to extract the 4,344 hypertension affected
sibling pairs (ASPs) from the total collection of
FBPP study participants and subject all of these
ASPs to a single, comprehensive and uniform
linkage analysis, as well as linkage analyses
within the different racial groups and field
centers. These analyses are based on the max-
imum likelihood-based multipoint linkage statis-
tic described by Devlin et al. [2002], which takes
advantage of the triangle constraints for ASP allele
sharing, as described by Holmans [1993], and has
many desirable properties. This statistic has been
shown to be less affected by a lack of complete
marker informativity than many other statistics
and, hence, is appropriate for analyses involving
disparate data sets for which variation in marker
informativity may be an issue [Kong and Cox,
1997; Schork and Greenwood, 2004a,b; Cordell,
2004; Franke and Ziegler, 2005].
In addition, we have also considered analyses
that accommodate linkage heterogeneity. Statisti-
cal analysis methods for accommodating hetero-
geneity in linkage analysis settings of complex,
multifactorial diseases have been proposed in the
literature [Chakravarti et al., 1987; Matise and
Weeks, 1993; Devlin et al., 2002]. Virtually all
of these statistical methods exploit a ‘‘mixture
model’’ approach to accommodate heterogeneity
by considering a parameter in their formulations,
which is used to estimate the fraction of families
or sibling pairs in the sample that are providing
evidence for linkage to a particular locus [Schork
et al., 1996]. The remainder of the families is
hypothesized to have the phenotype or disease in
question because of factors beyond those asso-
ciated with the locus being tested. Unfortunately,
detecting evidence for linkage heterogeneity using
mixture model approaches requires large sample
sizes [Devlin et al., 2002].
We have therefore considered the application
of the linkage heterogeneity mixture model
proposed by Devlin et al. [2002] to the same
4,344 ASPs from the FBPP. For these analyses we
chose the statistic derived by Devlin et al. [2002],
since it is based on the more traditional maximum
likelihood-based linkage statistic described above.
Our results provide further support for loci on
chromosome 2 that are likely to influence hyper-
tension. In addition, we find evidence that other
loci, most notably on chromosome 17, are linked
to hypertension that were not likely to be detected
without accommodating heterogeneity in the
analysis. In addition, our analyses, which involve
one of the largest collections of families geno-
typed at the same marker loci in the world, further
support the notion that linkage analysis appro-
aches to complex, multifactorial traits and dis-
eases require large sample sizes and sophisticated




Since the FBPP consists of four different
research networks, each with its own sampling
methods and population foci, we briefly describe
them in isolation below. We also consider the
relevance of the ascertainment strategies used in
each to the definition of the hypertension pheno-
type and each network’s contribution to the total
number of ASPs used in our analysis.
TABLE I. Summary of maximum LOD scores observed in previous linkage analyses of the FBPP data by the various
networks
Study Network Program used Results
Rao et al. [2003] HyperGEN MAPMAKER/SIBS Maximum LOD of 2.26 at 61 cM on 2p in African Americans
with severe hypertension
Thiel et al. [2003] GenNet GENEHUNTER2 Maximum LOD of 2.96 at 170 cM on 1q in Whites for blood pressure
Kardia et al. [2003] GENOA GENEHUNTER2 Nothing 41.0
Ranade et al. [2003] SAPPHIRe ASPEX Maximum LOD of 2.50 at 30 cM on 10p for Asians with hypertension
Province et al.
[2003]
All Meta-analysis Maximum LODs of 1.08 (combined sample) and 2.15 (Asians)
at 28 cM on 10p for blood pressure
Wu et al. [2006] All Meta-analysis Maximum LOD of 1.91 at 80 cM on 2p for hypertension (all) and 2.29
at 109 cM on 14q for hypertension1systolic BP (whites)
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GenNet has recruited Caucasian subjects from
Tecumseh, MI, as well as African American
subjects from Maywood, IL. While the other
networks ascertained families via probands with
a clinical diagnosis of hypertension (via, e.g.,
medication use as opposed to diagnoses involving
only BP measurements), GenNet focused on the
genetic determinants of BP levels by treating BP
as a continuously distributed quantitative trait.
To achieve this, GenNet has focused on sampling
younger individuals as probands whose BPs
were in the upper portion of the BP distribution
for their age and gender. Relatives of the pro-
bands were then ascertained irrespective of their
BP levels. Participants from this network were
classified as having hypertension if they were
taking at least one anti-hypertensive medication,
had a diastolic BP Z90 mmHg, or a systolic BP
Z140 mmHg.
GENOA has three field centers: one in Jackson,
MS, which has recruited African Americans; one
in Rochester, MN, which has recruited Caucasians;
and one in Starr County, TX, which has recruited
Mexican Americans. The field centers in Jackson
and Rochester have focused on the recruitment of
sibships containing at least two individuals with
hypertension diagnosed before the age of 60. The
field center in Starr County recruited sibships
containing at least two individuals with adult
onset diabetes in an attempt to overcome the
confounding effects of the high prevalence of
non-insulin-dependent diabetes in the Mexican
American population [Hanis et al., 1983].
HyperGEN has recruited African American and
Caucasian hypertensive siblings (and their parents
when available) from field centers in Birmingham,
AL; Forsyth County, NC; Framingham, MA;
Minneapolis, MN; and Salt Lake City, UT. Hyper-
GEN was designed to increase statistical power
by recruiting sibships preferentially via probands
with ‘‘severe’’ hypertension, defined as systolic BP
Z160 mmHg, diastolic BP Z100 mmHg, or the use
of two or more antihypertensive medications.
Nearly 80% of the sibships sampled in each racial
group have members that meet the ‘‘severe’’
hypertension definition.
SAPPHIRe focused its investigation on Asian
Pacific populations of Chinese and Japanese origin
residing in Taiwan (NTU, TSGH, and VGH
hospitals), Hawaii, and California (Stanford).
Two types of sibling pairs were recruited: those
concordant for hypertension and those with one
hypertensive individual and one individual with
low BP. SAPPHIRe defined a hypertensive indivi-
dual as one having a systolic BP Z160 mmHg, a
diastolic BP Z95 mmHg, or who is taking two anti-
hypertensive medications. SAPPHIRe also allowed
the recruitment of individuals with an alternative
definition of hypertension in which the subject
had uncontrolled hypertension, i.e., was taking
one medication for high BP and had either systolic
BP Z140 mmHg or diastolic BP Z90 mmHg.
MICROSATELLITE GENOTYPING
All FBPP study participants were genotyped for
a common set of 387 highly polymorphic auto-
somal microsatellite markers by the National
Heart, Lung, and Blood Mammalian Genotyping
Service at the Marshfield Clinic in Marshfield,
WI [http://research.marshfieldclinic.org/genetics/].
These markers have an average heterozygosity of
80% and an average intermarker distance of 10 cM.
Genotype data for all individuals were cleaned as
described by Chang et al. [2006]. The order and map
positions of all 371 autosomal markers studied were
estimated using a comprehensive, integrated,
genetic map that has been recently developed based
on the deCODE genetic map and current versions
of the human genome sequence [Kong et al., 2002;
Nievergelt et al., 2004].
STATISTICAL ANALYSES
The 4,344 ASPs were divided by field center
(i.e., locations where individuals were sampled)
and further subdivided by ethnicity to generate a
total of 18 separate data sets, as shown in Table II.
The linkage package Merlin [Abecasis et al., 2002]
was used to compute the probabilities that the
sibling pairs shared 0, 1, and 2 alleles identical-by
descent (IBD) (p0, p1, and p2) at each locus con-
sidered in the genome scan. Loci were tested at
1 cM intervals within the chromosomal regions
spanned by the marker loci. All available relatives
were used to compute allele-sharing probabilities,
despite the fact that only ASPs were ultimately
analyzed for linkage. Note that the IBD allele
sharing calculations were performed on indivi-
duals within each of the 18 field center ethnicity
groups separately, thereby making use of allele
frequencies calculated only from those individuals
when parental data were not available.
The linkage analyses involved the construction
of two test statistics at each locus: a maximum
likelihood-based multipoint linkage model (MML)
assuming homogeneity and a maximum likeli-
hood-based mixture model designed to accom-
modate linkage heterogeneity [Devlin et al., 2002].
198 Greenwood et al.
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For the mixture model, we used the likelihood
formulation discussed by Devlin et al. [2002] for
which a single parameter, a, which quantifies the
fraction of sibling pairs providing evidence for
linkage, is estimated along with a parameter, l,
that quantifies the locus-specific risk of develop-
ing hypertension [Risch, 1990].
For these analyses, l was treated as a nuisance
parameter and not reported, since its estimation is
likely to be inaccurate and our primary interest
was in the linkage heterogeneity (i.e., a) and the
overall evidence that there was linkage to a locus
(i.e., the resulting LOD scores). A great advantage
of the use of the maximum likelihood-based
statistics described by Devlin et al. [2002] in
mixture model settings is that when the para-
meter, a, is set equal to 1.0 the statistic reduces to
the statistic and model for homogeneity (i.e., the
‘‘MML’’ statistic described above).
Each of the 18 data sets of ASPs was analyzed
alone and/or in combination with other sibling
pair data sets as follows: (1) For each ethnicity
within a field center for which at least 100 ASPs
were available, mixture model and non-mixture
model LOD scores were calculated based on the
IBD estimates at 1-cM intervals across the genome;
(2) IBD estimates for ASPs of the same ethnicity
from different field centers were combined across
networks for analysis, including those from data
sets that did not contain enough ASPs for an
individual analysis; and (3) IBD estimates for
ASPs from all ethnicities and all field centers were




In order to determine the probabilistic signifi-
cance of the linkage analysis results, we under-
took focused, locus-specific simulation studies
[Ott, 1989; Doerge and Churchill, 1996]. These
studies were conducted by simulating ASPs
10,000 times with the same locus-specific informa-
tion content as in the actual sample using a
rejection sampling technique and recording the
fraction of times a simulated LOD score exceeded
the actual observed LOD score [for a discussion
on how and why to pursue such simulations,
see Schork and Greenwood, 2004b; Franke and
Zeigler, 2005]. We note that the use of an ASP,
locus-specific rejection sampling scheme to gene-
rate locus-specific significance levels is more
computationally demanding than simulation
studies appropriate for non-ASP linkage analysis
settings. This is because in non-ASP settings one
can randomize the phenotype and preserve the
marker data. In ASP analysis settings one must
simulate the marker data, but in a way that
preserves the locus-specific allele sharing infor-
mation content (not necessarily only the flanking
marker informativity). To do this, one can gene-
rate simulated data sets and then ‘reject’ those
whose locus-specific information does not match
the original sample. Thus, a large number of
simulated data sets may only produce a relatively
small number of data sets that match the locus-
specific information of relevance. This fact pre-
cluded us from pursuing simulation studies to
assess significance on a genome-wide scale for all
48 separate genome scans. The resulting p-values
represent the number of simulations producing
LOD scores greater than the observed LOD scores
divided by 10,000 (i.e., the number of accepted
simulations).
The mixture model has an additional parameter
which must be accounted for in the assessment
of its significance. To account for it, our locus-
specific simulation studies used to assess the
significance of the mixture model test statistics
involved fitting mixture models to simulated data
generated under the null hypothesis of no linkage
and no heterogeneity. Hence, resulting percentage
points for the distribution of the mixture model
test statistic were obtained in a way that considers




As emphasized, our analyses focused exclu-
sively on hypertension status as a qualitative
phenotype. The number of ASPs extracted from
the total number of FBPP participants for each
of the 18 field center ethnicity groups (or ‘‘data
sets’’) is described in Table II. As noted in the
methods section, those data sets for which the
total number of ASPs was less than 100 were not
subjected to an independent linkage analysis,
although those pairs were included in analyses
involving combined data sets. Table II also pro-
vides a breakdown on the percentages of males
and females in the study, as well as the ages of
the study participants. The younger average age
of participants from the GenNet network reflects
its specific ascertainment scheme and focus on
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younger individuals with high BP. Table II also
provides the average body mass index (BMI)
and BPs of the individuals used in the analysis.
Note that these averages were calculated with
BP measurements gathered on individuals taking
anti-hypertensive medications and, as such, are
lower than one would expect if all the individuals
used in the analysis were not on medication.
LINKAGE ANALYSES
Table III lists the loci resulting from the linkage
analyses that produced MML LOD scores greater
than 1.0. This listing includes analyses involving
each of the 18 field center ethnicity data sets
individually, as well as the combined analyses of
racial groups across field centers and the entire
TABLE III. Summary of all maximum multipoint LOD scores 41.0 and their simulated p-values
Chrom Field center Ethnicity Location (cM) MML LOD p-value
1 Minneapolis Caucasian 130 2.71 0.0003
1 Hawaii Japanese 240 1.25
1 — Japanese 240 1.46
2 Forsyth County African American 63 1.20
2 — All Ethnicities 65 2.63 0.0003
2 Minneapolis Caucasian 74 1.86
2 Starr County Mexican American 79 1.79
3 Starr County Mexican American 58 2.54 0.0004
3 Starr County Mexican American 176 1.09
5 Minneapolis Caucasian 65 1.64
5 Starr County Mexican American 115 1.12
5 — Chinese 163 1.33
5 Taiwan VGH Chinese 169 1.93
6 Starr County Mexican American 75 3.10 o0.0001
9 Minneapolis Caucasian 117 2.14 0.0010
9 Forsyth County African American 150 3.57 o0.0001
10 Taiwan VGH Chinese 26 2.64 o0.0001
10 Salt Lake City Caucasian 31 1.19
10 Starr County Mexican American 32 1.34
10 Forsyth County African American 40 1.46
10 Minneapolis Caucasian 84 1.33
11 Hawaii Japanese 22 3.53 o 0.0001
11 — Japanese 22 3.01 o 0.0001
11 — Asian 25 1.26
11 Birmingham African American 90 1.07
12 Minneapolis Caucasian 100 1.74
14 Hawaii Japanese 55 1.19
14 — Japanese 55 1.12
14 — Asian 83 1.31
14 — Chinese 84 1.47
14 Rochester Caucasian 115 1.60
16 Taiwan NTU Chinese 45 1.77
16 Rochester Caucasian 69 1.19
16 Hawaii Japanese 128 1.03
17 — All Ethnicities 46 1.36
17 Salt Lake City Caucasian 60 1.45
17 Rochester Caucasian 84 1.13
17 Taiwan NTU Chinese 130 1.14
19 Jackson African American 15 1.20
21 Salt Lake City Caucasian 36 1.51
22 Framingham Caucasian 23 1.74
Bold indicates a LOD score 42.0.
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combined sample. LOD scores greater than 3.0
were observed for the Starr County Hispanic data
set on chromosome 6, the Forsyth County African
American data set on chromosome 9, and the
Hawaiian Japanese data set, as well as the
combined Japanese data set, on chromosome 11.
LOD scores greater than 2.0 were observed for the
entire sample on chromosome 2, the Minneapolis
Caucasian data set on chromosomes 2 and 9,
the Starr County Mexican American data set on
chromosome 3, and the Taiwan VGH Chinese data
set on chromosome 10.
To determine the probability of obtaining LOD
scores greater than those observed, we resorted to
simulation studies, as described in the methods
section. The results of the simulation studies for
all LOD scores 42.0 are also listed in Table III.
These simulation studies revealed that many of
the observed LOD scores 42.0 have less than a 1
in 10,000 probability of occurring purely by
chance and hence can be considered ‘‘suggestive
of linkage’’ on a genome-wide scale [Lander and
Kruglyak, 1995].
To check that our simulation studies were
conducted properly, we also derived simulated
p-values for multiple regions producing LOD
scores o1.0 for a number of different data sets
and their combinations. These LOD scores should
produce p-values that are higher than those for the
regions with LOD scores 42.0. The LOD scores
examined ranged from 0.01 to 0.44 and involved,
for example, the Starr County Mexican American
data set with 416 sibling pairs, the Forsyth County
African American data set with 121 sibling pairs,
the Minneapolis Caucasian data set with 297
sibling pairs, and the combined data set with
4,344 sibling pairs. The p-values resulting from
these studies ranged from 0.09 to 1.00, consistent
with the fact that these LOD scores were quite
likely to have arisen by chance given the number
of loci that were studied.
We also considered regions of the genome
where there appeared to be consistency in LOD
‘‘peaks’’ across different data sets, as depicted in
Figure 1. Chromosome 2 showed some evidence of
consistency of linkage results with the Minneapolis
Caucasian data set, the Forsyth County African
American data set, the Starr County Mexican
American data set, and the entire data set all
mapping to a 20 cM region with a peak at 65 cM.
Chromosome 10 displayed coincident evidence
for linkage with the Taiwan VGH Chinese, the Salt
Lake City Caucasian, the Starr County Mexican
American, and the Forsyth County African
American data sets all mapping to a region
spanning less than 20 cM with a peak at 26 cM.
Two other chromosomes provide evidence for
potential linkage heterogeneity. The 22–25 cM
region of chromosome 11 provided evidence for
linkage from the Hawaiian Japanese data set, the
combined Japanese data set, and the combined
Asian data set. We note that the analysis involving
the Hawaiian Japanese data set provided a LOD
of 3.53 at 22 cM, and the addition of only 11
Japanese ASPs from Stanford to form the com-
bined Japanese data set reduced the LOD score to
3.01. This LOD score was further diluted to 1.26 in
the combined Asian data set with the addition
of 448 Chinese ASPs that did not exhibit linkage
to this region. Chromosome 14 also provided
some evidence for heterogeneity. The Hawaiian
Japanese and the combined Japanese data sets
showed some evidence for linkage at 55 cM, while
the combined Chinese and combined Asian data
sets showed slightly greater evidence for linkage
at 83–84 cM and no evidence for linkage at 55 cM.
LINKAGE HETEROGENEITY ANALYSES
Table IV provides results of the mixture model
analysis in addition to analyses using the non-
mixture model MML statistic for those loci and
data subsets for which the mixture model im-
proved the evidence for linkage as compared to
the MML and produced LOD scores 41.0. It can
be seen that the MML statistic and its extended
version that includes a mixing parameter reflect-
ing the fraction of sibling pairs contributing
evidence for linkage yield very similar results;
i.e., in general, the mixture model did not improve
the LOD score appreciably for subsets of the
data with sample sizes on the order of a couple
hundred sibling pairs. This is consistent with the
estimates of the mixture parameter, a, which are
generally in the range of 0.1–0.4, since 10% or 40%
of a few hundred families (i.e., 20–80 families)
are not likely to provide appropriate power to
detect linkage. However, analyses involving large
samples do provide compelling evidence for
linkage heterogeneity. For example, loci on chro-
mosomes 2 and 17 showed improvements in LOD
score when heterogeneity was accounted for and
assessed in the combined (i.e., larger and more
comprehensive) samples. These results are also
consistent with the MML non-mixture model
analyses in that some evidence for linkage was
found using different subsets (i.e., field center or
202 Greenwood et al.
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racial groups) of the data at these loci, but not in
others, indicating potential heterogeneity.
To assess the statistical properties and signifi-
cance of our mixture model analysis results, we
pursued simulation studies as described in the
Methods section. Table IV also provides the results
of these studies for the chromosomal regions that
yielded LOD scores 42.0. It can be seen that the
mixture model generally improved evidence for
linkage when the sample size was large and/or
the mixing parameter (a) was small. Two notable
findings involved regions on chromosomes 2 and
17, where there was minimal evidence for linkage
using non-mixture models but significant evi-
dence when heterogeneity was assumed.
To further explore the potential linkage hetero-
geneity on chromosome 2, we tabulated the results
of MML statistical analyses for the different subsets
of the data (i.e., individuals from different field
centers and racial groups) and examined them.
Table V displays the results, and it can be seen that a
few of the subsets provided evidence for linkage and
others do not, which is indicative of heterogeneity
and anticipates the results of the application of the
mixture model. Figure 1 displays the mixture model
results for the five chromosomes for which hetero-
geneity appears present as a function of chromoso-
mal location and data subset. Figure 2 emphasizes
the difference in non-mixture model analysis and
mixture model analysis results for chromosomes 2
and 17. Figure 3 displays the improvement in LOD
scores when heterogeneity is accommodated.
Complete linkage and linkage heterogeneity
results for all chromosomes for all data sets are
available at on our website [http://polymorphism.
ucsd.edu/articles.html].
DISCUSSION
We have pursued a comprehensive analysis of
sibling pairs affected with hypertension abstrac-
ted from the FBPP sample collection. Our analysis
was designed to overcome potential problems that
could have plagued previous analyses of the FBPP
data, as well as linkage studies of hypertension in
general. First, we did not pursue a meta-analysis
of individual linkage results, but rather combined
the data across a number of data collection sites
for analysis in combination, as well as in isolation.
TABLE IV. Summary of the maximum mixture model LODs 41.0, corresponding heterogeneity estimates (a) and MML
LODs, and simulated p values for all mixture model LODs 42.0
Mixture model
Chrom Field center Ethnicity Location (cM) MML LOD LOD Alpha p-value
2 — All Ethnicities 19 0.00 2.01a 0.12 0.0002
— Caucasian 40 0.66 1.31a 0.16
Forsyth County African American 63 1.20 1.21 0.64
— African American 63 0.48 1.12a 0.12
— All Ethnicities 65 2.63 4.04a 0.28 o0.0001
Minneapolis Caucasian 74 1.86 1.87 0.36
Starr County Mexican American 79 1.79 1.83 0.32
3 — All Ethnicities 57 0.00 1.90a 0.08
Starr County Mexican American 58 2.54 2.57 0.36 0.0004
Minneapolis Caucasian 90 0.96 1.03 0.28
— Caucasian 97 0.37 1.06a 0.12
5 — All Ethnicities 160 0.00 1.28a 0.08
— African American 161 0.63 1.19a 0.12
— Chinese 164 1.33 1.39 0.24
Taiwan VGH Chinese 169 1.93 1.93 0.44
— All Ethnicities 73 0.00 1.30a 0.08
Starr County Mexican American 75 3.10 3.12 0.36 o0.0001
17 — All Ethnicities 46 1.36 3.17a 0.12 o0.0001
Salt Lake City Caucasian 60 1.45 1.54 0.28
— All Ethnicities 100 0.06 2.23a 0.12 0.0008
Note: Only LODs that improved from the MML with inclusion of the mixture model or ones that map to same position as others with
improved LOD scores are listed. Bold indicates LOD scores 42.0.
aA locus for which evidence for linkage increased substantially with the mixture model.
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We chose a phenotype (hypertension) that was
available across all of the data collection sites,
creating a total data set of 4,344 ASPs, one of the
largest collections of ASPs genotyped at the same
loci on record. Second, we used a uniform data
analysis strategy involving a maximum likeli-
hood-based linkage statistic that is known to be
more robust to problems associated with the ana-
lysis of non-completely informative marker data
from non-parametric linkage analysis perspectives
[Kong and Cox, 1997; Schork and Greenwood,
2004a,b; Cordell, 2004; Franke and Ziegler, 2005].
In pursuing this analysis we also considered the
use of allele frequencies calculated for each
marker from the individuals unique to each field
center and racial group, thereby minimizing
problems associated with allele sharing calcula-
tions that result from the use of inappropriate
allele frequencies [Weeks and Lange, 1992]. Third,
by analyzing the data from each field center
ethnicity group in isolation and in combination,
we could more appropriately assess the consis-
tency of linkage results across the different
groups.
Our current analyses have confirmed several
of the linkage results previously published by the
individual FBPP networks. The previous linkage
analysis of the HyperGEN network data reported
a maximum LOD score of 2.26 at 61 cM on
chromosome 2 in their African American subjects
with severe hypertension [Rao et al., 2003]. In
our analyses, we observed evidence for linkage to
this chromosomal region in the Forsyth County
African American data set from the HyperGEN
network with a LOD score of 1.20 at 63 cM, as well
as in the entire data set with a LOD score of 2.63
at 65 cM. HyperGEN also found evidence for
linkage to chromosome 1 with a LOD score of 1.41
at 125 cM in their African American sample and a
LOD score of 1.29 at 136 cM in their Caucasian
sample [Rao et al., 2003]. We found evidence for
linkage to this region as well as with a LOD score
of 2.71 at 130 cM in the Minneapolis Caucasian
data set from the HyperGEN network. The
previous linkage analysis of the SAPPHIRe net-
work data reported a maximum LOD score of 2.5
at approximately 30 cM on chromosome 10 in their
combined Asian sibpair sample [Ranade et al.,
2003]. In our analyses, we found a LOD score of
2.64 at 26 cM on chromosome 10 in the Taiwan
VGH data set from this network. We also observed
LOD scores 41.0 in this region for the Salt Lake
TABLE V. Maximum mixture LODs and corresponding heterogeneity estimates (a) for all field centers ethnicity
within a 10 cM interval of the peak LOD observed for all ethnicities at 67 cM on chromosome 2
Network Field center Ethnicity ] ASPs Mixture LOD a
GenNet Tecumseh Caucasian 43 — —
HyperGEN Forsyth County Caucasian 88 — —
HyperGEN Framingham Caucasian 227 0.00 0.08
HyperGEN Minneapolis Caucasian 297 1.87 0.36
HyperGEN Salt Lake City Caucasian 364 0.01 0.12
GENOA Rochester Caucasian 656 0.00 0.08
Combined — Caucasian 1,675 0.10 0.04
GenNet Maywood African American 51 — —
HyperGEN Birmingham African American 549 0.92 0.16
HyperGEN Forsyth County African American 121 1.21 0.64
GENOA Jackson African American 838 0.00 0.08
Combined — African American 1,559 1.12 0.12
GENOA Starr County Mexican American 416 1.83 0.36
SAPPHIRe Hawaii Chinese 35 — —
SAPPHIRe Stanford Chinese 33 — —
SAPPHIRe Taiwan NTU Chinese 107 0.44 0.24
SAPPHIRe Taiwan TSGH Chinese 106 0.00 0.08
SAPPHIRe Taiwan VGH Chinese 165 0.00 0.08
Combined — Chinese 446 0.00 0.08
SAPPHIRe Hawaii Japanese 237 0.00 0.08
SAPPHIRe Stanford Japanese 11 — —
Combined — Japanese 248 0.00 0.08
Combined — Asian 694 0.00 0.08
Combined — All Ethnicities 4,344 4.04 0.28
Bold indicates LOD scores 42.0.
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City Caucasian, Starr County Mexican American,
and Forsyth County African American data sets.
The initial meta-analysis of the FBPP data also
found evidence for linkage to this region with a
maximum LOD score of 2.15 in the combined
Asian sample and a LOD score of 1.08 cM in the
entire data set, each at 28 cM on chromosome 10.
We have also identified several regions of
linkage in this study that have not been previously
reported by the individual networks. We observed
LOD scores 43.0 for the Starr County Mexican
American data set at 75 cM on chromosome 6,
the Forsyth County African American data set
at 150 cM on chromosome 9, and the Hawaiian
Japanese data set at 22 cM on chromosome 11, as
well as a LOD score 42.5 for the Starr County
Mexican American data set at 58 cM on chromo-
some 3.
We had assumed that linkage heterogeneity
would manifest itself within the FBPP dataset,
since the FBPP study sampled individuals from
different field centers, from different racial
groups, from different genders and ages, and for
which slightly different hypertension diagnostic
criteria were used. We were thus pleased to find
evidence for heterogeneity at loci that provided
evidence for linkage in non-mixture model-based
analyses of subsets of the total sample, which
suggests that accommodating linkage hetero-
geneity in a non-parametric linkage analysis
setting in sufficiently large samples has potential
to identify linkages. For example, we show that
our previous finding of suggestive evidence for
linkage to 65 cM on chromosome 2 with a LOD
score of 2.63 (p 5 0.0003) in the entire data set
using standard linkage methods increased to
levels considered ‘‘significant’’ on a genome-wide
scale with a LOD score of 4.04 (po0.0001) when
we accounted for linkage heterogeneity in this











































Fig. 3. Linkage results for the mixture model and MML statistics in the entire combined sample on chromosomes 2 and 17.
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tively small proportion of the entire sample is
contributing to the linkage at this locus. Failure
to account for this heterogeneity initially resulted
in a weakened linkage signal that did not
reach genome-wide significance. Additionally, by
incorporating a mixture model, we observed
increased evidence for linkage to this region in
the combined African American sample with a
LOD of 1.12 (a5 0.12), compared to the LOD of
0.48 obtained using standard linkage methods.
This likely reflects the contribution of the Forsyth
County African American sample from the Hy-
perGEN network, which gave LOD scores of
about 1.20 using either the MLS or mixture model
and showed less evidence for heterogeneity than
the African American samples from other field
centers. We also observed suggestive evidence for
linkage to an additional region on chromosome 2
in the entire combined sample with a LOD score
of 2.01 (p 5 0.0002, a5 0.12) at 19 cM by account-
ing for linkage heterogeneity. Using traditional
MLS analyses, this same sample gave a LOD score
of 0.00 at this locus.
We also observed significant evidence for
linkage at 46 cM on chromosome 17 in the entire
combined sample with a LOD score of 3.17
(po0.0001, a5 0.12). Without accounting for link-
age heterogeneity, the observed LOD score at this
location was 1.36 because only 12% of the entire
sample shows linkage to this region. Previous
analyses of the HyperGEN network data revealed
a LOD score of 1.05 to a nearby region on
chromosome 17 in their Caucasian sample [Rao
et al., 2003]. The lack of even suggestive evidence
for linkage using traditional methods would have
caused this chromosomal region to be dismissed.
By incorporating a mixture model to account for
heterogeneity, we have found evidence that this
region warrants further investigation.
Despite some of the advantages upon which our
analysis approach has been built, there are some
issues that need to be explored in greater detail.
First, we abstracted sibling pairs affected with
hypertension from field centers whose definitions
of hypertension went beyond simple diagnoses
based on elevated BP readings, which could create
a subtle phenotypic heterogeneity. Thus, FBPP
field centers, such as those in SAPPHIRe, that
defined probands as individuals receiving more
than one anti-hypertensive medication, may
have a more severe form of hypertension than
the individuals with hypertension identified at
the GenNet field centers, where the elevated
BP criteria were emphasized. At the very least we
can say that our analyses involved individuals
known to have elevations in BP, with other clinical
outcomes (e.g., treatment resistance, medication
use, sustained BP elevations, secondary diseases,
etc.) providing indications of potential hetero-
geneity. Secondly, we combined males and
females, as well as individuals of different ages,
in our analyses in an effort to identify loci that
contribute to general or gross elevations in BP.
However, sex-specific or age-specific gene effects
would be masked as a result.
Ultimately, our analysis of the entire FBPP
data set using a uniform genetic map and set of
markers, as well as a robust data analysis method,
confirms linkage results from previous FBPP
linkage analyses, as well as analyses involving
other data sets. In addition, our comprehensive
re-analysis also suggests that additional loci
might have an effect on hypertension suscepti-
bility, but may be confined to particular racial
groups. This latter result suggests that hetero-
geneity in genetic effects may explain some of the
differences in linkage analysis results published
previously. Explorations of the additional factors
that may explain the linkage heterogeneity we
observed would also be appropriate. For example,
further analyses could explore subgroups of
patients that have similar profiles with respect to
additional variables collected on them (e.g., lipid
profiles, anthropometric features, biochemical
phenotypes, medication use, etc.). These addi-
tional variables and profiles could explain why
some subsets of individuals exhibit linkage to a
particular region while others do not, since the
mechanism these individuals possess that influ-
ences their hypertension could be, say, physio-
logically related to the other features they have
in common.
It is generally accepted that linkage hetero-
geneity is a feature of the genetic factors mediat-
ing hypertension susceptibility. Thus, there are
likely many different combinations of genetic risk
factors that, when present in a given individual,
will contribute to his or her hypertension suscept-
ibility. The number of such combinations is of
course an open question, and, as such, teasing
apart the resulting heterogeneity (of whatever
magnitude) will be difficult and will require
sophisticated data analysis techniques in addition
to appropriately large and diverse samples. In this
light, it is important to emphasize that non-
parametric linkage analysis methods designed to
unravel the genetic basis of complex, multifactor-
ial traits and diseases, such as BP and hyperten-
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sion, should consider heterogeneity as a potential
confounding factor. This is not often pursued,
however, perhaps due to lack of available and
appropriate statistical methods. What is of interest
in this context is the fact that parametric linkage
analysis tools used for monogenic diseases often
accommodate heterogeneity through the use of
mixture analyses and ‘‘family-specific’’ LOD score
analyses [see e.g., Ott, 1991].
Finally, it is now well-recognized that linkage
analysis is limited with respect to its power
to detect a locus effect, as well as its ability to
resolve the location of specific locus influencing
phenotypic expression [Risch and Merikangas,
1996]. As an alternative or complement to linkage
analysis, association studies should be pursued
[Risch and Merikangas, 1996; Altshuler et al., 2005].
Ultimately, association and linkage analysis strate-
gies applied in large-scale studies, such as the
FBPP, provide the potential for sorting out the very
likely heterogeneous genetic architecture, and/or
complex nature of the genetic determinants, of BP
variation and hypertension susceptibility.
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